Reilly, C. M. et al. A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support. Care Cancer 21, 1525–1550 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Panattoni, L. et al. Characterizing potentially preventable cancer- and chronic disease-related emergency department use in the year after treatment initiation: a regional study. J .Oncol. Pract. 14, e176–e185 (2018).

Article  PubMed  Google Scholar 

Henry, D. H. et al. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support. Care Cancer 16, 791–801 (2008).

Article  PubMed  Google Scholar 

Di Maio, M. et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J. Clin. Oncol 33, 910–915 (2015).

Article  PubMed  Google Scholar 

Laugsand, E. A. et al. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual. Life Outcomes 8, 104 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Basch, E. et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol. 7, 903–909 (2006).

Article  PubMed  Google Scholar 

Warrington, L. et al. Electronic systems for patients to report and manage side effects of cancer treatment: systematic review. J. Med. Internet Res. 21, e10875 (2019).

Article  PubMed  PubMed Central  Google Scholar 

LeBlanc, T. W. & Abernethy, A. P. Patient-reported outcomes in cancer care - hearing the patient voice at greater volume. Nat. Rev. Clin. Oncol. 14, 763–772 (2017).

Article  PubMed  Google Scholar 

Kotronoulas, G. et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J. Clin. Oncol. 32, 1480–1501 (2014).

Article  PubMed  Google Scholar 

Basch, E. et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J. Clin. Oncol. 34, 557–565 (2016).

Article  CAS  PubMed  Google Scholar 

Basch, E. et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 318, 197–198 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Denis, F. et al. Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA 321, 306–307 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Barbera, L. et al. Impact of Standardized Edmonton Symptom Assessment System use on emergency department visits and hospitalization: results of a population-based retrospective matched cohort analysis. JCO Oncol. Pract. 16, e958–e965 (2020).

Article  PubMed  Google Scholar 

Mir, O. et al. Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial. Nat. Med. 2, 1224–1231 (2022).

Article  Google Scholar 

Basch, E. et al. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA 327, 2413–2422 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Basch, E. et al. Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT Trial. JCO Clin. Cancer Inform. 4, 947–957 (2020).

Article  Google Scholar 

Lizée, T. et al. Cost-effectiveness of web-based patient-reported outcome surveillance in patients with lung cancer. J. Thorac. Oncol. 14, 1012–1020 (2019).

Article  PubMed  Google Scholar 

Carlotto, A., Hogsett, V. L., Maiorini, E. M., Razulis, J. G. & Sonis, S. T. The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue. Pharmacoeconomics. 31, 753–766 (2013).

Article  PubMed  Google Scholar 

Schmidt, T. et al. Improving patient-reported measures in oncology: a payer call to action. J. Manag. Care Spec. Pharm. 27, 118–126 (2021).

PubMed  Google Scholar 

Di Maio, M. et al. Electronic address: clinicalguidelines@esmo.org. The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. Ann. Oncol. 33, 878–892 (2022).

Article  PubMed  Google Scholar 

PROTEUS Consortium. The PROTEUS Guide to Implementing Patient-Reported Outcomes in Clinical Practice covers design, implementation, and management of PRO systems in clinical care. Available at: https://theproteusconsortium.org/wp-content/uploads/2023/04/PROTEUS-Practice-Guide.pdf. Accessed 1 October 2023.

Basch, E. & Abernethy, A. P. Commentary: encouraging clinicians to incorporate longitudinal patient-reported symptoms in routine clinical practice. J. Oncol. Pract. 7, 23–25 (2011).

Article  PubMed  PubMed Central  Google Scholar 

Patt, D. et al. Implementation of electronic patient-reported outcomes for symptom monitoring in a large multisite community oncology practice: dancing the Texas Two-Step through a pandemic. JCO Clin. Cancer Inform. 5, 615–621 (2021).

Article  Google Scholar 

Caston, N. E. et al. Evaluating nurses’ time to response by severity and cancer stage in a remote symptom monitoring program for patients with breast cancer. JCO Clin. Cancer Inform. 7, e2300015 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Basch, E., Rocque, G., Mody, G., Mullangi, S. & Patt, D. Tenets for implementing electronic patient-reported outcomes for remote symptom monitoring during cancer treatment. JCO Clin. Cancer Inform. 7, e2200187 (2023).

Article  PubMed  Google Scholar 

Rocque, G. B. et al. Adaptation of remote symptom monitoring using electronic patient-reported outcomes for implementation in real-world settings. JCO Oncol. Pract. 18, e1943–e1952 (2022).

Article  PubMed  PubMed Central  Google Scholar 

National Academies of Sciences, Engineering, and Medicine. Establishing Effective Patient Navigation Programs in Oncology: Proceedings of a Workshop (National Academies Press, 2018).

Patient-Reported Outcomes Core of the University of North Carolina. Available at: https://pro.unc.edu/. Accessed 20 July 2021.

Schoen, M. W. et al. Software for administering the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events: usability study. JMIR Hum. Factors. 5, e10070 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Basch, E., Barbera, L., Kerrigan, C. L. & Velikova, G. Implementation of patient-reported outcomes in routine medical care. Am. Soc. Clin. Oncol. Educ. Book. 38, 122–134 (2018).

Article  PubMed  Google Scholar 

National Cancer Institute. Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events. Available at: https://healthcaredelivery.cancer.gov/pro-ctcae. Accessed 20 July 2020.

Dueck, A. C. et al. Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 1, 1051–1059 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Al-Rashdan, A., Sutradhar, R., Nazeri-Rad, N., Yao, C. & Barbera, L. Comparing the ability of physician-reported versus patient-reported performance status to predict survival in a population-based cohort of newly diagnosed cancer patients. Clin. Oncol. (R. Coll. Radiol.) 33, 476–482 (2021). S0936-6555(21)00008-X.

Article  CAS  PubMed  Google Scholar 

de Souza, J. A. et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 123, 476–484 (2017).

Article  PubMed  Google Scholar 

Chung, A. E. et al. Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). J Am Med Inform Assoc. 26, 276–285 (2019).

Article  PubMed  PubMed Central  Google Scholar 

MacMahon, B. The National Death Index. Am. J. Public Health 73, 1247–1248 (1983).

Article  CAS  PubMed  PubMed Central  Google Scholar 

German, R. R. et al. The accuracy of cancer mortality statistics based on death certificates in the United States. Cancer Epidemiol. 35, 126–131 (2011).